The risk of developing pseudomyxoma peritonei from a non-perforated low grade appendiceal mucinous neoplasm found at appendicectomy.

Low grade appendiceal mucinous neoplasm Pseudomyxoma peritonei

Journal

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
ISSN: 1532-2157
Titre abrégé: Eur J Surg Oncol
Pays: England
ID NLM: 8504356

Informations de publication

Date de publication:
10 Aug 2024
Historique:
received: 05 05 2024
revised: 02 07 2024
accepted: 10 08 2024
medline: 22 8 2024
pubmed: 22 8 2024
entrez: 21 8 2024
Statut: aheadofprint

Résumé

Low-grade appendiceal mucinous neoplasms (LAMNs) are classified as non-perforated (pTis, pT3) or perforated (pT4), and considered precursors of pseudomyxoma peritonei (PMP). This study aims to quantify the risk of developing PMP from pTis and pT3 LAMNs. Retrospective analysis of a prospectively collected database identified LAMN patients referred to a specialist centre from 2004 to 2019. pT4 LAMNs and other appendix tumours were excluded. All patients had specialist review of their pathology, operation note, and a CT scan (at least 6 weeks post-operatively). Surveillance CTs were then performed at 6, 12, 24, 36, 48, & 60 months, with tumour markers (CEA, CA19-9, CA125). 193 pT3/pTis LAMN patients were included (pTis = 153, pT3 = 40). Median follow-up = 6.45 (3.91-22.13) years, M:F ratio = 1:1.57, and median age = 57 (23-83) years. Initial surgery included: appendicectomy (67 %), appendicectomy + visceral resection (6 %), and right hemicolectomy (27 %). R1 resections were identified in 5/193 patients (2.5 %). 3 R This is the largest reported series of pTis/pT3 LAMNs with standardised follow-up in the literature. LAMNs correctly classified as pT3/pTis (after careful specialist review of pathology, operation note, and a baseline post-operative CT) have negligible risk of developing PMP and should have low intensity surveillance. If completely excised, further surgery is not indicated. R1 resections should be considered on an individual basis at a specialist centre.

Identifiants

pubmed: 39167862
pii: S0748-7983(24)00652-8
doi: 10.1016/j.ejso.2024.108600
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

108600

Informations de copyright

Copyright © 2024 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest We the authors have no competing interests to declare regarding this submitted manuscript.

Auteurs

Chamila Lakmal (C)

Colorectal and Peritoneal Oncology Centre, The Christie NHS Foundation Trust, UK.

Bipasha Chakrabarty (B)

Colorectal and Peritoneal Oncology Centre, The Christie NHS Foundation Trust, UK.

Christine Tan (C)

Division of Cancer Sciences, University of Manchester, UK.

Lucy Larby (L)

Colorectal and Peritoneal Oncology Centre, The Christie NHS Foundation Trust, UK.

Rohit Kochhar (R)

Colorectal and Peritoneal Oncology Centre, The Christie NHS Foundation Trust, UK.

Rebecca Fish (R)

Colorectal and Peritoneal Oncology Centre, The Christie NHS Foundation Trust, UK; Division of Cancer Sciences, University of Manchester, UK.

Paul Sutton (P)

Colorectal and Peritoneal Oncology Centre, The Christie NHS Foundation Trust, UK; Division of Cancer Sciences, University of Manchester, UK.

Jonathan Wild (J)

Colorectal and Peritoneal Oncology Centre, The Christie NHS Foundation Trust, UK.

Hamish Clouston (H)

Colorectal and Peritoneal Oncology Centre, The Christie NHS Foundation Trust, UK.

Chelliah Selvasekar (C)

Colorectal and Peritoneal Oncology Centre, The Christie NHS Foundation Trust, UK.

Andrew G Renehan (AG)

Colorectal and Peritoneal Oncology Centre, The Christie NHS Foundation Trust, UK; Division of Cancer Sciences, University of Manchester, UK.

Malcolm Wilson (M)

Colorectal and Peritoneal Oncology Centre, The Christie NHS Foundation Trust, UK.

Sarah T O'Dwyer (ST)

Colorectal and Peritoneal Oncology Centre, The Christie NHS Foundation Trust, UK; Division of Cancer Sciences, University of Manchester, UK.

Omer Aziz (O)

Colorectal and Peritoneal Oncology Centre, The Christie NHS Foundation Trust, UK; Division of Cancer Sciences, University of Manchester, UK. Electronic address: omer.aziz2@nhs.net.

Classifications MeSH